Related references
Note: Only part of the references are listed.Optimal Active Anti-Thymocyte Globulin Exposure Associated with Minimum Risk of Virus Reactivation and Comparable Acute Graft-Versus-Host Disease Under Adult Myeloablative Haploidentical Peripheral Blood Stem Cell Transplantation
HaiTao Wang et al.
TRANSPLANTATION AND CELLULAR THERAPY (2022)
Efficacy of low dose antithymocyte globulin on overall survival, relapse rate, and infectious complications following allogeneic peripheral blood stem cell transplantation for leukemia in children
Hyun Mi Kang et al.
BONE MARROW TRANSPLANTATION (2021)
Impact of anti-thymocyte globulin dose for graft-versus-host disease prophylaxis in allogeneic hematopoietic cell transplantation from matched unrelated donors: a multicenter experience
Sara Butera et al.
ANNALS OF HEMATOLOGY (2021)
Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell Transplantation
Maria Queralt Salas et al.
TRANSPLANTATION AND CELLULAR THERAPY (2021)
Personalizing rabbit anti-thymocyte globulin therapy for prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation: is there an optimal dose?
Takafumi Shichijo et al.
BONE MARROW TRANSPLANTATION (2020)
Clinical impact of anti-thymocyte globulin on survival and graft-versus-host disease in patients undergoing human leukocyte antigen mismatched allogeneic stem cell transplantation
Taeyun Kim et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2020)
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
Olaf Penack et al.
Lancet Haematology (2020)
Graft-versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome
Sung-Soo Park et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Two dose levels of rabbit antithymocyte globulin as graft-versus-host disease prophylaxis in haploidentical stem cell transplantation: a multicenter randomized study
Ren Lin et al.
BMC MEDICINE (2019)
Impact of antithymocyte globulin doses in reduced intensity conditioning before allogeneic transplantation from matched sibling donor for patients with acute myeloid leukemia: a report from the acute leukemia working party of European group of Bone Marrow Transplantation
Raynier Devillier et al.
BONE MARROW TRANSPLANTATION (2018)
Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Frederic Baron et al.
HAEMATOLOGICA (2017)
Efficacy of antithymocyte globulin for allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis
Yasuyuki Arai et al.
LEUKEMIA & LYMPHOMA (2017)
Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Frederic Baron et al.
HAEMATOLOGICA (2017)
Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial
Franco Locatelli et al.
LANCET ONCOLOGY (2017)
Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a retrospective, pharmacodynamic cohort analysis
Rick Admiraal et al.
LANCET HAEMATOLOGY (2017)
Comparison of Different Rabbit Anti-Thymocyte Globulin Formulations in Allogeneic Stem Cell Transplantation: Systematic Literature Review and Network Meta-Analysis
Nico Gagelmann et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Optimal Dose of Rabbit Thymoglobulin in Conditioning Regimens for Unmanipulated, Haploidentical, Hematopoietic Stem Cell Transplantation: Long-Term Outcomes of a Prospective Randomized Trial
Ying-Jun Chang et al.
CANCER (2017)
International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium
Andrew C. Harris et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
The Impact of Antithymocyte Globulin (ATG) Dose in Allogeneic Hematopoietic Stem Cell Transplantation with HLA Mismatched Donors
Yunsuk Choi et al.
BLOOD (2016)
Dynamical System Modeling of Immune Reconstitution after Allogeneic Stem Cell Transplantation Identifies Patients at Risk for Adverse Outcomes
Amir A. Toor et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
Madan H. Jagasia et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Influence of two different doses of antithymocyte globulin in patients with standard-risk disease following haploidentical transplantation: a randomized trial
Y. Wang et al.
BONE MARROW TRANSPLANTATION (2014)
Low incidences of acute and chronic graft-versus-host disease after unrelated bone marrow transplantation with low-dose anti-T lymphocyte globulin
Kazuo Hatanaka et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2012)
Randomized phase II trial comparing two dose levels of thymoglobulin in patients undergoing unrelated donor hematopoietic cell transplant
Qaiser Bashir et al.
LEUKEMIA & LYMPHOMA (2012)
Improved Nonrelapse Mortality and Infection Rate with Lower Dose of Antithymocyte Globulin in Patients Undergoing Reduced-Intensity Conditioning Allogeneic Transplantation for Hematologic Malignancies
Mehdi Hamadani et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantation
Francis Ayuk et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: Long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation
A Bacigalupo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen
HJ Deeg et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report
AH Filipovich et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
No important influence of limited steroid exposure on bone mass during the first year after renal transplantation:: A prospective, randomized, multicenter study
CG ter Meulen et al.
TRANSPLANTATION (2004)
Dose study of thymoglobulin during conditioning for unrelated donor allogeneic stem-cell transplantation
M Remberger et al.
TRANSPLANTATION (2004)
Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML
M Schleuning et al.
BONE MARROW TRANSPLANTATION (2003)
Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen
M Mohty et al.
BLOOD (2003)
Chronic graft-versus-host disease
SJ Lee et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Antithymocyteglobulin as prophylaxis of graft failure and graft-versus-host disease in recipients of partially T-cell-depleted grafts from matched unrelated donors: A dose-finding study
E Meijer et al.
EXPERIMENTAL HEMATOLOGY (2003)
Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)
A Bacigalupo et al.
BLOOD (2001)
Share Paper
